Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

SCPCP000006_05_explore_COPYKAT #813

Merged
merged 11 commits into from
Oct 16, 2024
3 changes: 1 addition & 2 deletions analyses/cell-type-wilms-tumor-06/README.md
Original file line number Diff line number Diff line change
Expand Up @@ -19,7 +19,7 @@ The analysis is/will be divided as the following:
- [x] Metadata file: compilation of a metadata file of marker genes for expected cell types that will be used for validation at a later step
- [x] Script: clustering of cells across a set of parameters for few samples
- [x] Script: label transfer from the fetal kidney atlas reference using runAzimuth
- [ ] Script: run InferCNV
- [x] Script: run copykat and inferCNV
- [ ] Notebook: explore results from steps 2 to 4 for about 5 to 10 samples
- [ ] Script: compile scripts 2 to 4 in a RMardown file with required adjustements and render it across all samples
- [ ] Notebook: explore results from step 6, integrate all samples together and annotate the dataset using (i) metadatafile, (ii) CNV information, (iii) label transfer information
Expand Down Expand Up @@ -253,7 +253,6 @@ The `renv` lockfile is used to install R packages in the Docker image.

## Computational resources


## References

- [1] https://www.ncbi.nlm.nih.gov/books/NBK373356/
Expand Down
17 changes: 16 additions & 1 deletion analyses/cell-type-wilms-tumor-06/notebook/README.md
Original file line number Diff line number Diff line change
Expand Up @@ -34,4 +34,19 @@ In brief, we explore the clustering results, we look into some marker genes, pat
The next step in analysis is to identify tumor vs. normal cells.

- `04_annotation_Across_Samples_exploration.html` is the output of the [`04_annotation_Across_Samples_exploration.Rmd`](../notebook/04_annotation_Across_Samples_exploration.Rmd) notebook.
In brief, we explored the label transfer results across all samples in the Wilms tumor dataset SCPCP000006 in order to identify a few samples that we can begin next analysis steps with.
In brief, we explored the label transfer results across all samples in the Wilms tumor dataset SCPCP000006 in order to identify a few samples that we can begin next analysis steps with.

## Exploratory analysis

We selected in [`04_annotation_Across_Samples_exploration.Rmd`](../notebook/04_annotation_Across_Samples_exploration.Rmd) 5 samples to test for aneuploidy and CNV inference:
- sample SCPCS000194 has > 85 % of cells predicted as kidney and 234 + 83 endothelium and immune cells.
- sample SCPCS000179 has > 94 % of cells predicted as kidney and 25 + 111 endothelium and immune cells.
- sample SCPCS000184 has > 96 % of cells predicted as kidney and 39 + 70 endothelium and immune cells.
- sample SCPCS000205 has > 89 % of cells predicted as kidney and 92 + 76 endothelium and immune cells.
- sample SCPCS0000208 has > 95 % of cells predicted as kidney and 18 + 35 endothelium and immune cells.

We wanted to test `copykat` results obtained with or without normal cells as reference, using either an euclidean or statistical (spearman) method for CNV heatmap clustering.
This impact the final decision made by `copykat` for each cell to be either aneuploid or diploid, and it is thus crucial to explore the results using the different methods.
For each of the selected samples, we explore the results in the template `notebook` [`05_copykat_exploration.Rmd`](../notebook_template/05_copykat_exploration.Rmd), which creates a notebook `05_cnv_copykat_exploration_{sample_id}.html` for each sample.
These `notebooks` are inspired by the plots written for the Ewing Sarcoma analysis in [`03-copykat.Rmd`](https://github.com/AlexsLemonade/OpenScPCA-analysis/blob/main/analyses/cell-type-ewings/exploratory_analysis/03-copykat.Rmd).

Large diffs are not rendered by default.

Loading
Loading